Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2019 1
2020 2
2021 1
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Nootropic effects of LSD: Behavioral, molecular and computational evidence.
Ornelas IM, Cini FA, Wießner I, Marcos E, Araújo DB, Goto-Silva L, Nascimento J, Silva SRB, Costa MN, Falchi M, Olivieri R, Palhano-Fontes F, Sequerra E, Martins-de-Souza D, Feilding A, Rennó-Costa C, Tófoli LF, Rehen SK, Ribeiro S. Ornelas IM, et al. Among authors: silva srb. Exp Neurol. 2022 Oct;356:114148. doi: 10.1016/j.expneurol.2022.114148. Epub 2022 Jun 19. Exp Neurol. 2022. PMID: 35732217
TanP: A Multifunctional Anionic Peptide From Tityus stigmurus Scorpion Venom.
de Melo MMA, Oliveira VDS, de Queiroz Neto MF, Paiva WS, Torres-Rêgo M, Silva SRB, Pontes DL, Rocha HAO, de Souza MÂF, da Silva-Júnior AA, Fernandes-Pedrosa MF. de Melo MMA, et al. Front Mol Biosci. 2022 Jan 17;8:785316. doi: 10.3389/fmolb.2021.785316. eCollection 2021. Front Mol Biosci. 2022. PMID: 35111812 Free PMC article.
Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.
Falchi-Carvalho M, Wießner I, Silva SRB, O Maia L, Barros H, Laborde S, Arichelle F, Tullman S, Silva-Costa N, Assunção A, Almeida R, Pantrigo ÉJ, Bolcont R, Costa-Macedo JV, Arcoverde E, Galvão-Coelho N, Araujo DB, Palhano-Fontes F. Falchi-Carvalho M, et al. Eur Neuropsychopharmacol. 2024 Mar;80:27-35. doi: 10.1016/j.euroneuro.2023.12.006. Epub 2023 Dec 22. Eur Neuropsychopharmacol. 2024. PMID: 38141403 Clinical Trial.
Antileishmanial activity of 4-phenyl-1-[2-(phthalimido-2-yl)ethyl]-1H-1,2,3-triazole (PT4) derivative on Leishmania amazonensis and Leishmania braziliensis: In silico ADMET, in vitro activity, docking and molecular dynamic simulations.
Holanda VN, Silva WVD, Nascimento PHD, Silva SRB, Cabral Filho PE, Assis SPO, Silva CAD, Oliveira RN, Figueiredo RCBQ, Lima VLM. Holanda VN, et al. Bioorg Chem. 2020 Dec;105:104437. doi: 10.1016/j.bioorg.2020.104437. Epub 2020 Oct 28. Bioorg Chem. 2020. PMID: 33339081